KD
Katherine Dawson
Psychiatry & Neurology / Neurology
Credentials: ·
Research
Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis
New England Journal of Medicine · 2012 · 1,397 citations
Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis
New England Journal of Medicine · 2012 · 1,088 citations
The Lancet · 2008 · 386 citations

7 papers

7 papers

6 papers

6 papers
- JP
4 papers
- MN
4 papers
- CB
2 papers
- AS
1 paper
